Enanta's Hepatitis C Drug Candidate Designated as a 'Breakthrough Therapy'

Published May 7, 2013

Enanta's hepatitis C drug candidate designated as a 'breakthrough therapy'

Filed under: drug rehab treatment programs

A combination treatment regimen for hepatitis C in trials at AbbVie, which uses a drug candidate developed by Enanta Pharmaceuticals Inc., (Nasdaq: ENTA), has received Breakthrough Therapy designation from the U.S. Food and Drug Administration …
Read more on Boston Business Journal (blog)

Saving money on medical costs: Slowdown in health care spending growth …

Filed under: drug rehab treatment programs

"For whatever reason, the technology that's available for treating people seems to be improving at a slower rate than in the past," Cutler said. "In recent years, there have been a number of oncology drugs that have been touted as potential …
Read more on Science Daily (press release)

Facing a test of faith – Philly.com

Filed under: drug rehab treatment programs

The inmates had signed up for the New Leash on Life program because it offered relief from boredom and the chance for early parole. A month in, they … Respect, said Philadelphia Prisons Commissioner Louis Giorla, is also the most critical piece in an …
Read more on Philly.com